{ "items": [ "\n\n
\n \n Conference paper\n \n
\n \n\n \n \n \nJoedicke A. et al, (2022), Pharmacoepidemiology and drug safety, 31, 430 - 431
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nVerhamme KM. et al, (2022), European respiratory journal, 60
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nJodicke AM. et al, (2022), Aging clinical and experimental research, 34, S45 - S45
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nWall AJW. et al, (2022), Rheumatology, 61, I114 - I114
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nLi X. et al, (2022), Pharmacoepidemiology and drug safety, 31, 76 - 77
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nTan EHC. et al, (2022), Pharmacoepidemiology and drug safety, 31, 633 - 634
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nXie J. et al, (2022), Front pharmacol, 13
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRobinson DE. et al, (2021), J bone miner res, 36, 2153 - 2161
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKhalid S. et al, (2021), J bone miner res, 36, 2162 - 2176
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nXie J. et al, (2021), Jama, 326, 1504 - 1515
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSkj\u00f8dt MK. et al, (2021), Osteoporos int, 32, 1961 - 1971
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFerguson R. et al, (2021), Bmj open, 11
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFerguson R. et al, (2021), Bmj open, 11
\n \n \n \n\n \n
\n \n \n\n \n Working paper\n \n
\n \n\n \n \n \nLi X. et al, (2021)
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHawley S. et al, (2021), Rheumatology (oxford), 60, 4055 - 4062
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nXie J. et al, (2021), Pharmacoepidemiology and drug safety, 30, 164 - 164
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBurn E. et al, (2021)
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \n(2021), Pharmacoepidemiol drug saf, 30 Suppl 1, 3 - 439
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nOda T. et al, (2021)
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nJodicke A. et al, (2021)
\n \n \n \n\n \n
\n \n \n